Winnipeg, Manitoba
December 18, 2003
Background
As part of the regulatory requirement in Canada for plants with
novel traits, Monsanto has
been actively involved in the variety registration process
administered through the Prairie Regional Recommending Committee
on Grains (PRRCG) and the Canadian Food Inspection Agency
(CFIA). There is keen interest in the development of Roundup
Ready wheat in Western Canada and the annual PRRCG review is a
focal point for those involved in wheat variety development.
Monsanto has been an active and willing participant in the PRRCG
process for the past several years.
Up to this point, Monsanto s involvement at the PRRCG has
included three years of testing for agronomic, disease and
quality attributes. PRRCG members have been involved in
reviewing the field trial protocols and conducting the Private
Registration trials on behalf of Monsanto.
Monsanto has now completed the required three years of field
testing of several of our Roundup Ready wheat lines and is in a
position to request recommendation for registration from the
PRRCG at its 2004 annual meeting to be held in Saskatoon,
February 24-26, 2004. However, Monsanto does not intend to
bring forward any of our current lines for recommendation at the
2004 Annual Meeting. As per previous years, we will be
requesting acceptance of the 2003 data and acceptance of the
private registration trial protocol for 2004. We will also
request a 4th year of testing for the Roundup Ready BW251 lines.
The decision not to bring forward any of our current lines for
recommendation was made after extensive review and discussion
with both internal and external stakeholders, and is in keeping
with the milestones we have set for the responsible and positive
introduction of Roundup Ready wheat.
We are actively working to develop a system in
Canada that will allow the regulatory approval and variety
registration processes to take place, while providing the
Canadian government and industry with assurances that Roundup
Ready wheat will not be commercially available until we have met
all of the milestones we have outlined. We have also publicly
communicated that the introduction of Roundup Ready wheat as a
commercial product is not imminent. As such, the decision not to
ask for variety recommendation in 2004 has no commercial impact
on this project. We remain fully committed to this project and
continue to make good progress against each of our milestones
Key Points
Monsanto Canada will not be bringing forward any lines for
recommendation at the February 2004 PRRCG Annual Meeting.
This decision is in keeping with the milestones we have set for
the positive and responsible introduction of this product.
As publicly communicated on many occasions, the introduction of
Roundup Ready wheat as a commercial product is not imminent.
Therefore, our decision to not bring forward varieties for
review in February 2004 has no commercial impact on this
project.
We remain fully committed to this project and continue to make
good progress against each of our milestones.
We acknowledge and respect the complexities of today s trade and
export environment. We are working diligently with the wheat
industry to identify how a biotech trait can successfully enter
the marketplace. Roundup Ready wheat will be introduced only
when
ALL
the following milestones have been achieved:
o Regulatory Approvals The food, feed and environmental safety
of Roundup Ready wheat is demonstrated, resulting in regulatory
approvals in the United States, Canada and Japan.
o International Standards Appropriate regulatory approvals,
thresholds or marketing arrangements are in place in key export
markets.
o Grain Handling System Appropriate grain handling protocols and
standardized sampling and detection methods are developed and
implemented.
o Stewardship Programs Comprehensive, agronomic stewardship
programs and best management practices are developed.
o Quality The varieties meet or exceed industry standards for
grain end-use quality.
o Market Acceptance Buyers are identified who will procure and
use wheat ingredients with biotech traits. |